Eventide Asset Management »

Denali Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $13M 622k 20.63
2023-06-30 $9.2M 313k 29.51
2023-03-31 $7.2M 313k 23.04

More positions owned by Eventide Asset Management

Guardant Health (GH)
Mirum Pharmaceuticals (MIRM)
Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Insmed Com Par $.01 (INSM)
Lam Research Corp Com New (LRCX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Scholar Rock Hldg Corp (SRRK)
Beta Bionics (BBNX)
Argenx Se Sponsored Adr (ARGX)
Roper Industries (ROP)
Vistra Energy (VST)
Axsome Therapeutics (AXSM)
Toast Cl A (TOST)

View all positions for Eventide Asset Management

Top funds holding Denali Therapeutics

Baillie Gifford & Co
BlackRock
Vanguard Group
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics